Inhalation

INH1018

Issue link: https://www.e-digitaleditions.com/i/1032386

Contents of this Issue

Navigation

Page 10 of 31

The 2018 AAPS annual meeting, now named PharmSci360, will be held November 4-7, 2018 in Washington, DC, US. Inhalation October 2018 9 Previewing PharmSci360 2018 The 2018 AAPS annual meet- ing, now named PharmSci360, will be held November 4-7, 2018 in Washington, DC, US. Keynote topics will include the US Food and Drug Administration's (FDA's) perspective on drug/device combination products, organ-on-a- chip, and modeling and simulation in development and regulator y applications. Lecture tracks will be: preclinical development, bioana- lytics, clinical pharmacology, man- ufacturing and bioprocessing, and formulation and quality. e topic of rapid and cost-effective delivery of new drugs to patients will have daily symposia in each track. The conference will also feature scientific posters and a technology exhibition. When? November 4-7, 2018 Where? Washington, DC, US For more information and registration: www.aaps.org/annual- meeting-and-conferences/ annual-meeting Driving Successful Drug Delivery by Bridging the Gaps between Patient Usage, Device Performance, and Formulation Learn more at: goproveris.com/labstudies F O R M U L A T I O N P A T I E N T U S A G E D E V I CE P E R F O R M A NCE FDA pre-conference workshop A November 3 pre-conference workshop given by FDA represen- tatives will use presentations, b r e a k o u t s e s s i o n s a n d m o c k pre-Abbreviated New Drug Appli- cation meetings to discuss develop- ment of generic drugs, including orally inhaled and nasal drug prod- ucts, challenges of bioequivalence, in vitro testing, product quality evaluation and FDA Guidances.

Articles in this issue

Links on this page

view archives of Inhalation - INH1018